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Objective: We wanted to identify the geographic differences in hepatic fibrosis and their associations with the atrophy-
hypertrophy complex in patients with chronic viral hepatitis using the dual-contrast material-enhanced MRI (DC-MRI) with 
gadopentetate dimeglumine and ferucarbotran.
Materials and Methods: Patients with chronic C (n = 22) and B-viral hepatitis (n = 35) were enrolled for determining the 
subjective grade of fibrosis (the extent and thickness of fibrotic reticulations) in the right lobe (RL), the caudate lobe (CL), 
the medial segment (MS) and the lateral segment (LS) of the liver, with using a 5-grade scale, on the gradient echo T2*-
weighted images of DC-MRI. The fibrosis grades of different segments were compared using the Kruskal-Wallis test followed 
by post-hoc analysis to establish the segment-by-segment differences. The incidences of two pre-established morphologic 
signs of cirrhosis were also compared with each other between the two groups of patients.
Results: There were significant intersegmental differences in fibrosis grades of the C-viral group (p = 0.005), and the CL 
showed lower fibrosis grades as compared with the grades of the RL and MS, whereas all lobes were similarly affected in the 
B-viral group (p = 0.221). The presence of a right posterior hepatic notch was significantly higher in the patients with 
intersegmental differences of fibrosis between the RL and the CL (19 out of 25, 76%) than those without such differences 
(6 out of 32, 19%) (p < 0.001). An expanded gallbladder fossa showed no significant relationship (p = 0.327) with the 
segmental difference of the fibrosis grades between the LS and the MS. 
Conclusion: The relative lack of fibrosis in the CL with more advanced fibrosis in the RL can be a distinguishing feature to 
differentiate chronic C-viral hepatitis from chronic B-viral hepatitis and this is closely related to the presence of a right 
posterior hepatic notch.
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INTRODUCTION
Chronic viral hepatitis is a common cause of hepatic 
fibrosis and this results in cirrhosis complicated with 
hepatocellular insufficiency, portal hypertension and an 
increased risk of hepatocellular carcinoma (1). During the 
generation of hepatic fibrosis, atrophy of the right lobe (RL) 
and medial segment (MS), and hypertrophy of the caudate 
lobe (CL) and lateral segment (LS) could induce expansion 
of the gallbladder fossa or formation of a right posterior 
hepatic notch (2). Even though this atrophy-hypertrophy 
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complex has been used to explain the early morphologic 
changes of the liver related to the geographic differences 
of portal venous perfusion or hepatic venous drainage, most 
of the reports on this were based on observations of the 
patients in the United States or Japan (3, 4), where the 
alcoholic hepatitis or chronic hepatitis C virus infection 
predominates. Yet in clinical practice in our country, this 
atrophy-hypertrophy complex is not so frequently observed 
and especially in the cirrhotic patients with chronic 
hepatitis B viral infection. Because hepatitis B virus is 
usually associated with macronodular cirrhosis and hepatitis 
C virus is usually associated with micronodular cirrhosis (5, 
6), we hypothesized that the distribution of hepatic fibrosis 
would differ depending on the type of viral infection, and 
this might be related to the recently reported differing 
prevalence of the fibrosis-induced gross morphologic signs 
between the two types of viral infection (7). 
Dual-contrast material-enhanced MRI (DC-MRI) is 
primarily applied for the assessment of focal lesions, but 
it also allows for gross inspection of the reticular fibrosis 
in the background liver (8). Gadolinium chelates display 
a gradual distribution into fibrotic tissue, thereby causing 
delayed enhancement of the hepatic septal fibrosis during 
T1-weighted imaging. Superparamagnetic iron oxides 
(SPIOs) accumulate within the reticuloendothelial cells of 
the liver, causing T2 and T2* shortening, and this decreases 
the signal intensity of the background parenchyma and 
the regenerating nodules in the cirrhotic liver. Based on 
a gradient-echo T1-weighted sequence with a longer echo 
time for T2*-weighted imaging, it was possible to assess 
the grades of hepatic fibrosis with accuracy comparable 
to that of histopathologic analysis (8). Therefore, we also 
hypothesized that direct visualization of reticular fibrosis 
would enable us to evaluate the geographic differences of 
the fibrotic changes and their associations with the atrophy-
hypertrophy complex of different lobes and segments in 
cirrhotic livers. 
Although this study is primarily for academic interest 
rather than having a direct clinical impact for patients’ care, 
the purpose of this study was to identify the geographic 
differences in hepatic fibrosis arising from chronic B or 
C virus-induced hepatitis and their associations with the 
morphologic changes of the atrophy-hypertrophy complex 
with the use of DC-MRI.
MATERIALS AND METHODS
Patients
This retrospective study was approved by our institutional 
review board, and the requirement for informed consent 
of the individual patients was waived. By surveying an 
electronic database of the patients’ records from August 
2005 to December 2007, we identified 24 patients with 
chronic hepatitis C virus infection (the C-viral group) 
who underwent DC-MRI with gadopentetate dimeglumine-
enhanced dynamic imaging and ferucarbotran-enhanced 
delayed phase imaging (8) in the same session at our 
institution for further examination of suspected hepatic 
lesions seen by other imaging modalities. We enrolled 
a total of 22 C-viral group patients (M:F = 17:5; age 
range, 54-81 years; mean age, 65.5 years). Two patients 
had been previously treated by transcatheter arterial 
chemoembolization (TACE) (n = 1) or hepatic resection 
(n = 1) and they were excluded because these treatments 
could affect the evaluation of hepatic fibrosis on MR 
images. We also enrolled 35 consecutive patients during 
a 6-month period from July 2007 to December 2007 with 
chronic hepatitis B virus infection (the B-viral group, M:F 
= 26:9; age range, 40-70 years; mean age, 53.8 years) who 
underwent the same protocol during the same period. Viral 
infection was diagnosed by a viral antigen test and by 
antibody titration, and all patients had a 10-year or longer 
history of chronic hepatitis. At the time of MRI, the Child-
Pugh classification of each group of patients was as follows: 
the C-viral group (class A: n = 14, class B: n = 2, class C: n 
= 3, no available data: n = 3) and the B-viral group (class A: 
n = 24, class B: n = 8, class C: n = 3). 
MR Imaging Techniques 
MR imaging was performed with a 3 Tesla (T) unit 
(Signa EXCITE; GE Medical Systems, Milwaukee, WI) for 
13 C-viral group patients or with a 1.5T unit (Magnetom 
Avanto; Siemens, Erlangen, Germany) for all B-viral group 
patients and nine C-viral group patients. Dynamic contrast-
enhanced imaging was obtained using a 3D gradient echo 
(GRE) sequence with ultrafast image reconstruction in the 
axial plane by employing parallel imaging algorithms. The 
1.5T unit was used under the following conditions: VIBE 
(volumetric interpolated breath-hold examination), GRAPPA 
(generalized autocalibrating partially parallel acquisition) 
factor: 2, repetition time (TR): 4.4 ms, echo time (TE): 2.1 m, 
flip angle: 10°, matrix: 448 × 224, field of view (FOV): 271 
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× 379 mm, slice thickness: 5 mm, slice spacing, 2.5 mm and 
slices: 72. The 3T unit was used under these conditions: 
LAVA (liver acquisition with volume acceleration), ASSET 
(array spatial sensitivity encoding technique) factor: 2, TR/
TE: 3.5-4.2/1.0-1.2 msec, flip angle: 10°, matrix: 320 × 
256, slice thickness: 5 mm, slice spacing: 2.5 mm, slices 
and 64 depending on the MRI vendor. A dynamic series 
consisted of one precontrast series followed by three 
postcontrast series, including the arterial, portal and five-
minute delayed phase imaging. The postcontrast series 
was performed after administering a bolus injection of 0.1 
mmol/kg gadopentetate dimeglumine (Magnevist; Bayer 
HealthCare Pharmaceuticals Inc., Wayne, NJ) at a rate of 2 
mL/sec followed by a saline flush using a power injector.
After the dynamic imaging, ferucarbotran (8 µmol iron/
kg of Resovist; Bayer HealthCare Pharmaceuticals Inc.) was 
intravenously administered as the second contrast agent 
of SPIO. After 10 minutes, the T2-weighted fast spin-echo 
and T1-weighted double echo chemical shift gradient-echo 
images were obtained using the same parameters as for 
the pre-contrast imaging. A gradient-echo sequence with 
a longer echo time (TR/TE: 134/10 msec, flip angle: 35° 
or TR/TE: 196/10 msec, flip angle: 30° depending on the 
MRI vendor) was added for the post-SPIO T2*-weighted 
imaging. All scans were sent to our picture archiving and 
communication system (PACS) for interpretation on PACS 
workstations.
Image Evaluation
Two independent radiologists with 15 and one years of 
experience, respectively, in hepatic MRI retrospectively 
reviewed the images in a random order on four side-by-
side picture archiving and communicating system monitors, 
where each gray-scale image was at a 2048 × 2560-pixel 
resolution (Totoku, Tokyo, Japan). The reviewers were 
blinded to the demographic, clinical, laboratory and 
pathology data at the time of the image review. For grading 
the fibrosis, the liver was divided into 4 segments: RL, 
CL, MS and LS. Based on the DC-MRI depiction of hepatic 
fibrosis as proposed by Aguirre et al. (8), the fibrosis grade 
of each hepatic segment was subjectively assessed using a 
5-grade scale from 0: reticulations are not visible on any 
section to 4: diffuse reticulations are obvious in the entire 
segment on the post-SPIO T2*-weighted gradient-echo 
images.
To evaluate the association between the previously-
defined morphologic signs of cirrhosis and the presence 
of geographical differences of reticular fibrosis, the 
intersegmental differences of the fibrosis grade of MS versus 
LS, and RL versus CL were compared with the presence of 
the expanded gallbladder fossa sign and the right posterior 
hepatic notch sign, respectively (3, 4). The expanded 
gallbladder fossa sign was considered present if the 
gallbladder was bound medially by the edge of the lateral 
segment of the left hepatic lobe below the lowermost 
portion of the medial segment (3), and the right posterior 
notch sign was considered to be present when there was 
a sharp indentation in the right medial posterior surface 
of the liver (4). The intersegmental difference in hepatic 
fibrosis was defined as differences of one or more fibrotic 
grades between the relevant hepatic segments. The portal 
phase images of a 3D dynamic series (2.5 mm section 
thickness) were used to determine the presence or absence 
of the two morphological signs. To minimize discrepancy in 
the subjective grading of hepatic fibrosis and the presence 
of morphological signs between the two observers, a 
consensus was reached for further analyses in all cases after 
the calculating the interobserver variation. 
Statistical Analysis
Interobserver agreement was assessed with the linear 
weighted kappa statistics for the fibrotic grade or the 
kappa statistics for the presence of morphological signs, 
respectively. The level of agreement was defined as follows: 
a kappa value of 0.2 or less indicated poor agreement, 0.2-
0.4 indicated fair agreement, 0.4-0.6 indicated moderate 
agreement, 0.6-0.8 indicated good agreement and 0.8-1.0 
indicated excellent agreement.
The Child-Pugh class of each group of patients were 
compared with each other using Chi-square tests. The 
Mann-Whitney test was used to assess the difference of 
the overall fibrotic severity between the C-viral and B-viral 
groups. For each chronic hepatitis group, the fibrosis grades 
of different segments were compared using the Kruskal-
Wallis test followed by post-hoc analysis (Tukey’s test) to 
establish the segment-by-segment differences. Pearson’s 
chi-square test or Fisher’s exact test was used to assess the 
relationship between the presence of morphological signs 
and the intersegmental differences (1 or a larger score in 
each patient) of the hepatic fibrosis. A p value of less than 
0.05 was considered significant. The statistical analysis was 
done using Sigmaplot, version 10.0 for Windows. 
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RESULTS
The weighted kappa values for the assessment of the 
fibrosis grading and the morphologic signs of cirrhosis 
were 0.61 and 0.65, respectively. This means that the 
interobserver agreements were good for both analyzed 
items. The results of the fibrotic grades and their 
comparisons between the C-viral and B-viral groups are 
shown in Table 1. The mean value of the fibrotic grade of 
the RL was highest, followed by that in the MS, LS and CL 
in the C-viral group. For the Child-Pugh classification, there 
was no remarkable difference between each of the viral 
groups (p = 0.914). There were significant differences of the 
fibrosis grades of each of the hepatic segments in the C-viral 
group (p = 0.005), and by multiple pairwise comparisons 
using Tukey’s test, the CL showed a significantly lower 
degree of fibrosis compared to that of the RL and MS, 
while there were no significant intersegmental differences 
for the RL, MS and LS (p > 0.05) (Figs. 1, 2). There was a 
marginal difference of fibrosis between the CL and LS in the 
C-viral group (p = 0.048). In the B-viral group, there was 
no statistically significant difference in the fibrosis grade 
among the different segments (p = 0.221) (Fig. 3).
Among the 57 patients, all eight patients with more 
advanced fibrosis of the MS, as compared to the LS, had 
signs of an expanded gallbladder fossa (100%), whereas 
40 (82%) of the remaining 49 patients with homogeneous 
fibrosis had the same signs (p = 0.327) (Table 2). The signs 
of a right posterior hepatic notch were significantly higher 
in the patients with intersegmental differences of fibrosis 
(19 out of 25, 76%) between the RL and CL as compared to 
that of the other patients (6 out of 32, 19%) (p < 0.001) 
(Table 2).
DISCUSSION
To date, a number of methods have been proposed for the 
non-invasive identification of hepatic fibrosis; these include 
serum marker panels and conventional imaging techniques 
such as ultrasonography, CT and conventional MRI based 
on the morphological consequences of fibrosis and the 
stigmata of portal hypertension (2-4, 9-12). The advanced 
imaging technologies have recently enabled non-invasive 
tests that reflect the full spectrum of hepatic fibrosis and 
cirrhosis and its severity in liver diseases (8, 13, 14). One 
of them is DC-MRI as suggested by Aguirre et al. (8), and 
Fig. 1. 60-year-old man with C-viral induced cirrhosis. 
A. Double contrast material-enhanced gradient echo (196/10 msec) T2*-weighted image obtained by 1.5T unit depicts diffuse 
hyperintense reticulations in entire liver except area of hypertrophic caudate lobe (arrowheads). B. On transverse 3D gradient echo MR 
images (4.4/2.1 msec) below level of A, right posterior hepatic notch (arrow) is seen between right lobe and caudate lobe. C. Transverse 
3D gradient echo MR image (4.4/2.1 msec) demonstrates medial portion of lateral segment (arrowhead) is separated from gallbladder 
(asterisk) without intervening with medial segment, and this represents expanded gallbladder fossa sign below level of B.
A B C
Table 1. MRI Fibrosis Grades of C-Viral and B-Viral 
Groups (57 Patients)
Fibrosis Grading
C-Viral Group 
(n = 22 )
B-Viral Group 
(n = 35 )
Caudate lobe 1.86 ± 1.08 2.36 ± 1.10
Right lobe 2.91 ± 1.06 2.77 ± 0.94
Medial segment 2.77 ± 0.97 2.70 ± 0.94
Lateral segment 2.48 ± 0.96 2.40 ± 1.07
P value 0.005 0.221
Note.— Data are mean ± standard deviation. P values are for 
difference between results from C-viral group and B-viral group.
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by using this method, one could achieve direct visualization 
of the reticular fibrosis and regenerating nodules, as well 
as an accuracy of greater than 90% for diagnosing the 
grade of fibrosis, which is an accuracy comparable to that 
achieved using histopathology analysis. In the latest study 
of ours (7), we found a close relationship between the 
prevalence of gross morphologic signs and the degree of 
hepatic fibrosis in the entire liver as determined on DC-MRI. 
Moreover, according to the results of our previous study 
(7), there was a substantial difference in the appearance 
of gross morphologic signs between the hepatitis B and C 
viral infections that cause hepatic fibrosis. Depending on 
the ability to directly visualize the entire liver, DC-MRI can 
be expected to define the possible geographic or segmental 
differences of the fibrotic change, which would not be 
uniform across the entire organ. It can also be presumed 
Table 2. Correlation between Intersegmental Differences 
of Fibrotic Grades and Two Morphologic Signs of Hepatic 
Fibrosis in 57 Patients with Chronic Viral Hepatitis
MS versus LS†
Expanded Gallbladder Fossa Sign
+ -
+ 8 (14%) 0
- 40 (70%) 9 (16%)
P value 0.327
RL versus CL‡
Right Posterior Hepatic Notch Sign
+ -
+ 19 (33%) 6 (11%)
- 6 (11%) 26 (46%)
P value < 0.001
Note.— Numbers are number of patients. †Intersegmental 
difference (≥ 1 in each patient) of fibrosis grade between 
medial and lateral segments of left lobe, ‡Intersegmental 
difference (≥ 1 in each patient) of fibrosis grade between 
right lobe and caudate lobe. + = present, - = not present, CL = 
caudate lobe, LS = lateral segment of left hepatic lobe, MS = 
medial segment of left hepatic lobe, RL = right lobe
Fig. 2. 61-year-old man with C-viral induced cirrhosis. 
A. Double contrast material-enhanced gradient echo (140/5.8 msec) images obtained by 3T unit depict diffuse involvement of reticular 
fibrosis involving entire liver except for small portion of caudate lobe (arrowheads). B. There is no hypertrophy of caudate lobe and 3D 
gradient echo (4.0/1.0 msec) image shows smooth curvature of right posterior medial margin of liver (arrowheads) without any notch 
formation.
A B
Fig. 3. 60-year-old woman with B-viral induced cirrhosis. 
Double contrast material-enhanced gradient echo (196/10 msec) 
T2*-weighted hepatic MR image obtained by using 1.5T unit 
depicts homogeneous reticular fibrosis involving entire liver 
without any evidence of caudate lobe hypertrophy.
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that there would be a relationship between the gross 
morphologic signs and the segmental distribution of hepatic 
fibrosis in each of the viral hepatitis groups of patients in 
the present study.
Using DC-MRI, our results indicate that the CL is 
significantly spared from fibrosis compared with the RL 
and MS, and especially in those patients with hepatitis 
C. Several mechanisms have been suggested to explain 
the sparing of the CL; these relate to the geographic 
differences in the portal venous perfusion, which result in 
volume redistribution in the cirrhotic liver (9, 15). Portal 
venous blood is essential for liver regeneration because of 
the various trophic factors in it (16). Because the portal 
veins in the CL have a shorter intrahepatic course than do 
the other vessels and because of the proximity veins to 
the main portal vein, in addition to the short accessory 
hepatic veins, the portal blood flow and the hepatic 
venous drainage of the CL might be less affected by fibrotic 
distortion than the other lobes. The main portal vein splits 
into the right and left lobar branches at the porta hepatis, 
and the right portal vein branch enters directly into the 
parenchyma of the right lobe. Progression of hepatic 
fibrosis gradually attenuates the intrahepatic portal venous 
branches and the hepatic venous branches, thereby reducing 
the hepatic vascular bed (17). Compression of the hepatic 
venous tributaries by regenerating nodules or fibrosis 
impairs drainage of blood from the liver, which increases 
the resistance to portal flow and decreases the right portal 
blood flow (18). The left lobar branch of the portal vein 
courses outside the liver parenchyma along the ligamentum 
venosum before entering into the hepatic parenchyma, 
resulting in a relatively greater blood supply to the left 
lobe.
One of the most interesting findings in the present study 
was the lack of remarkable intersegmental differences in 
hepatic fibrosis in those patients with hepatitis B. One 
potential explanation is the different pathological factors 
between the two groups. Cirrhosis can be divided by the 
gross pathology into micronodular, macronodular and mixed-
forms according to the size of the regenerating nodules. In 
those patients with hepatitis B, the size of the regenerative 
nodules is heterogeneous. However, in this patient group 
there are more macronodules, and the intervening fibrotic 
septa are thinner than that in the patients with hepatitis 
C, who tend to have micronodules with thicker septa (19). 
Nagula et al. (20) demonstrated that small nodularity and 
thick septa are independent predictors of the presence of 
clinically significant portal hypertension. Thick septa would 
induce wide tissue collapse and passive obstruction to 
the portal venous flow. Small nodules are also indicative 
of greater damage and greater architectural distortion 
and the small nodules will further increase intrahepatic 
resistance (21). We can speculate that during the early 
stage of hepatic fibrosis, the fibrotic process might be 
geographically different depending on the inherent 
segmental differences of the portal venous perfusion 
pressure. It is well known that compared with the CL, the 
RL is more peripherally located from the hepatic hilum and 
the portal venous perfusion pressure is relatively lower. The 
different perfusion pressure gradients between the CL and 
RL would increase the portal blood flow to the CL due to 
the CL’s low resistance to portal venous perfusion, while the 
RL would receive less portal venous perfusion due to the 
RL’s higher resistance. In the patients of the C-viral group, 
thick septal fibrosis and micronodules will induce more 
profound regional variations of the portal perfusion within 
the liver and they will synergistically induce more profound 
regional variations of the hepatic fibrosis, as compared to 
that of the hepatitis B patients with macronodules and thin 
septa. The geographical heterogeneity of hepatic fibrosis 
observed in our study was grossly correlated with the 
gross hepatic volume redistribution in the right posterior 
notch, indicating atrophy-hypertrophy of the RL and CL. 
As is observed in daily practice, in advanced macronodular 
cirrhosis, the fibrotic reticulations and regenerative nodules 
tend to be more evenly distributed within the whole 
liver, and CL hypertrophy and the appearance of the right 
posterior hepatic notch are uncommon. For most of the 
hepatitis B patients with thin fibrotic septa and larger 
regenerating nodules in our present study, the regional 
or intersegmental variation in the portal perfusion seems 
to be too small to cause apparent geographic differences, 
regardless of the stage of hepatic fibrosis.
Although all eight patients with a higher fibrosis grade 
in the MS as compared to that in the LS had an expanded 
gallbladder fossa, we could not find meaningful differences 
of the incidence of this morphologic sign between these 
patients and the others due to the overall high prevalence 
of this sign in the patients without such segmental 
differences. Initially, we expected that the signs of an 
expanded gallbladder fossa would appear more frequently 
in the patients with segmental differences in fibrosis 
between the LS and the MS, like the condition between 
the CL and the RL. Besides the limited number of patients 
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who showed different fibrotic grades between the LS and 
the MS, there may be another explanation for the lack of 
statistical significance. Unlike other hepatic segments, the 
portal venous perfusion in the MS is easily decreased in the 
early stage of hepatic fibrosis. This is due to the unique 
anatomical direction of the portal venous flow observed 
with using color Doppler ultrasonography (22). The flow in 
the portal vein branches of the LS and the CL is uniformly 
hepatopetal, whereas the MS often receives circular or 
hepatofugal flow from the right side of the umbilical 
segment with less blood than the other segments (23). 
Even during early fibrosis, which cannot be grossly depicted 
on DC-MRI, the overall portal venous perfusion is usually 
reduced in the entire liver, and the flow to the MS would 
be more deteriorated and minimized earlier than the flow 
in the other segments, resulting in segmental atrophy (23). 
For the high prevalence of expanded gallbladder fossa signs 
regardless of the intersegmental difference between the MS 
and the LS in the present study, the expanded gallbladder 
fossa sign may develop before the gross appearance of 
reticular fibrosis.
This study has several limitations. Our patients did not 
have histopathologically confirmed liver cirrhosis; however, 
meticulous fibrosis grading of each hepatic segment for 
the explanted livers or multiple biopsy procedures for 
each segment for this purpose would not be practical. It 
should be emphasized that we focused on the relative 
differences of the fibrosis grades among the hepatic 
segments rather than on the absolute fibrosis grade in 
each hepatic segment. Second, our study was limited by 
the small size of the C-viral group compared to that of the 
B-viral group in our country, and the B-viral patients were 
randomly selected for comparative analyses. However, there 
was no difference in the overall fibrotic severity between 
the C-viral and B-viral groups, and we believe that there 
were no considerable selection biases that would alter the 
results of this study. Finally, we know our study was not like 
previous studies that determined the severity of cirrhosis to 
support the treatment plan in cirrhotic patients. Our study 
was motivated by academic interest from the observations 
in daily practice. Moreover, the differential diagnosis 
between C-viral and B-viral on DC-MRI would not have a 
big clinical implication in the practical manner. We just 
hoped to contribute insight on the hemodynamic changes 
in the cirrhotic liver depending on the viral type along with 
a better understanding of the morphological changes of 
cirrhotic livers.
In conclusion, DC-MRI demonstrated the geographic or 
intersegmental differences of hepatic fibrosis in the C-viral 
group as distinguished from those of the B-viral group, and 
there were no remarkable variations among the different 
hepatic segments. Our results suggest that the relative lack 
of fibrosis in the CL and the more advanced fibrosis in the 
RL causes a right posterior hepatic notch, and especially 
in the patients with chronic C-viral hepatitis, whereas 
expansion of the gallbladder fossa is not closely related to 
the intersegmental differences in hepatic fibrosis regardless 
of the sorts of the viruses.
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